TickerFacts.

Edwards Lifesciences Corp (EW): Cost of Revenue

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2022-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$1.33B
Year ended 2025-12-31
$1.44B
Trailing 12 months to 2026-06-30
+22.6%
3-year compound annual growth
2008-12-31: $419.60M2009-12-31: $399.10M2010-12-31: $408.30M2011-12-31: $489.80M2012-12-31: $491.00M2013-12-31: $516.60M2014-12-31: $625.60M2015-12-31: $617.20M2016-12-31: $797.40M2017-12-31: $875.30M2018-12-31: $939.40M2019-12-31: $1.11B2020-12-31: $1.08B2021-12-31: $1.25B2022-12-31: $723.70M2023-12-31: $978.40M2024-12-31: $1.12B2025-12-31: $1.33B$1.33B
2008-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$1.33B+19.4%2026-02-25, From 2025-01-01
2024-12-31$1.12B+14.2%2026-02-25, From 2024-01-01
2023-12-31$978.40M+35.2%2026-02-25, From 2023-01-01
2022-12-31$723.70Mn/c2025-02-28, From 2022-01-01
2021-12-31$1.25B+15.6%2024-02-12, From 2021-01-01
2020-12-31$1.08B-3.0%2023-02-13, From 2020-01-01
2019-12-31$1.11B+18.6%2022-02-14, From 2019-01-01
2018-12-31$939.40M+7.3%2021-02-12, From 2018-01-01
2017-12-31$875.30M+9.8%2020-02-14, From 2017-01-01
2016-12-31$797.40M+29.2%2019-02-15, From 2016-01-01
2015-12-31$617.20M-1.3%2018-02-16, From 2015-01-01
2014-12-31$625.60M+21.1%2017-02-17, From 2014-01-01
2013-12-31$516.60M+5.2%2016-02-19, From 2013-01-01
2012-12-31$491.00M+0.2%2015-02-20, From 2012-01-01
2011-12-31$489.80M+20.0%2014-02-28, From 2011-01-01
2010-12-31$408.30M+2.3%2013-02-28, From 2010-01-01
2009-12-31$399.10M-4.9%2012-02-27, From 2009-01-01
2008-12-31$419.60Mn/a2011-02-28, From 2008-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Orthopedic, Prosthetic & Surgical Appliances & Supplies), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
Edwards Lifesciences Corp (EW)2025-12-31$1.33B+19.4%
Steris PLC (STE)2026-03-31$3.31B+8.3%
Zimmer Biomet Holdings, Inc. (ZBH)2025-12-31$2.49B+13.8%
Align Technology Inc (ALGN)2025-12-31$1.32B+10.3%
Intuitive Surgical Inc (ISRG)2025-12-31$3.42B+25.9%
Enovis Corp (ENOV)2025-12-31$902.79M-2.6%
MSA Safety Inc (MSA)2025-12-31$1.00B+5.9%
Cadre Holdings, Inc. (CDRE)2025-12-31$350.68M+5.0%
Inogen Inc (INGN)2025-12-31$194.40M+7.4%

Compare EW, STE, ZBH, ALGN side by side · Screen every company in Orthopedic, Prosthetic & Surgical Appliances & Supplies ↗